- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Potential application of mesenchymal stem cell-derived exosomes as a novel therapeutic drug
-
- Katsuda Takeshi
- Division of Molecular and Cellular Medicine,National Cancer Center Research Institute
-
- Ochiya Takahiro
- Division of Molecular and Cellular Medicine,National Cancer Center Research Institute
Bibliographic Information
- Other Title
-
- 新規治療薬開発への間葉系幹細胞由来エクソソームの応用可能性
- シンキ チリョウヤク カイハツ エ ノ カンヨウケイ カンサイボウ ユライ エクソソーム ノ オウヨウ カノウセイ
Search this article
Description
Secreted membrane vesicles called exosomes play important roles in intercellular communications. Exosomes contain various molecules such as proteins, microRNAs and mRNAs, and mimic, at least in part, the roles that are played by their originating cells. Thus, it is expected that mesenchymal stem cells (MSC)-derived exosomes (MSC-exosomes) can serve as drugs for various types of diseases, because MSCs have attracted much attention as a novel therapeutic source for a wide range of diseases. In this article, we will summarize the latest reports on the therapeutic potential of MSC-exosomes for several types of diseases. We also discuss possible therapeutic strategies using MSC-exosomes, and hurdles to be overcome for realization of MSC-exosome based therapy.
Journal
-
- Drug Delivery System
-
Drug Delivery System 29 (2), 140-151, 2014
THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204642782592
-
- NII Article ID
- 130004495151
-
- NII Book ID
- AN10084591
-
- ISSN
- 18812732
- 09135006
-
- NDL BIB ID
- 025370522
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed